Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1972 Feb 12;1(5797):426–428. doi: 10.1136/bmj.1.5797.426

Tuberculosis--chemotherapy.

K M Citron
PMCID: PMC1787330  PMID: 4109997

Full text

PDF
426

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennedsen J., Larsen S. O. Examination for tubercle bacili by fluorescence microscopy. Scand J Respir Dis. 1966;47(2):114–120. [PubMed] [Google Scholar]
  2. Bignall J. R. Daily and intermittent regimens: third IUAT chemotherapy investigation. A controlled trial of three regimens of self-administered and supervised chemotherapy for pulmonary tuberculosis. Clinical aspects. Bull Int Union Tuberc. 1970 Jun;43:253–254. [PubMed] [Google Scholar]
  3. Bobrowitz I. D., Robins D. E. Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis. Am Rev Respir Dis. 1967 Sep;96(3):428–438. doi: 10.1164/arrd.1967.96.3.428. [DOI] [PubMed] [Google Scholar]
  4. Boisvert H. Action de l'acide pyruvique sur la croissance et l'antibiogramme des mycobactéries. Rev Tuberc Pneumol (Paris) 1970;34(1):117–124. [PubMed] [Google Scholar]
  5. CHAPMAN J. S., DEWLETT H. J., POTTS W. E. Cutaneous reactions to unclassified mycobacterial antigens. A study of children in household contact with patients who excrete unclassified Mycobacteria. Am Rev Respir Dis. 1962 Oct;86:547–552. doi: 10.1164/arrd.1962.86.4.547. [DOI] [PubMed] [Google Scholar]
  6. CROW H. E., CORPE R. F., SMITH C. E. Is serious pulmonary disease caused by nonphotochromogenic ("atypical'') acid-fast Mycobacteria communicable? Dis Chest. 1961 Apr;39:372–381. doi: 10.1378/chest.39.4.372. [DOI] [PubMed] [Google Scholar]
  7. CSILLAG A. Morphological and biochemical features of 'atypical' mycobacteria. J Gen Microbiol. 1961 Feb;24:261–272. doi: 10.1099/00221287-24-2-261. [DOI] [PubMed] [Google Scholar]
  8. Cook P. L., Riddell R. W., Simon G. Bacteriological and radiographic features of lung infection by opportunist mycobacteris: a review. Tubercle. 1971 Sep;52(3):232–241. doi: 10.1016/0041-3879(71)90046-8. [DOI] [PubMed] [Google Scholar]
  9. Devadatta S., Dawson J. J., Fox W., Janardhanam B., Radhakrishna S., Ramakrishnan C. V., Velu S. Attack rate of tuberculosis in a 5-year period among close family contacts of tuberculous patients under domiciliary treatment with isoniazid plus PAS or isoniazid alone. Bull World Health Organ. 1970;42(3):337–351. [PMC free article] [PubMed] [Google Scholar]
  10. Evans C., Devadatta S., Fox W., Gangadharam P. R., Menon N. K., Ramakrishnan C. V., Sivasubramanian S., Somasundaram P. R., Stott H., Velu S. A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone. Bull World Health Organ. 1969;41(1):1–16. [PMC free article] [PubMed] [Google Scholar]
  11. FOX W., WIENER A., MITCHISON D. A., SELKON J. B., SUTHERLAND I. The prevalence of drug-resistant tubercle bacilli in untreated patients with pulmonary tuberculosis; a national survey, 1955-56. Tubercle. 1957 Apr;38(2):71–84. doi: 10.1016/s0041-3879(57)80001-4. [DOI] [PubMed] [Google Scholar]
  12. Hobby G. L., Redmond W. B., Runyon E. H., Schaefer W. B., Wayne L. G., Wichelhausen R. H. A study on pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria. 18. A report of the Veterans Administration-Armed Forces Cooperative Study. Am Rev Respir Dis. 1967 Jun;95(6):954–971. doi: 10.1164/arrd.1967.95.6.954. [DOI] [PubMed] [Google Scholar]
  13. Hughes M. H. Pyruvic acid egg medium for tubercle bacilli. J Clin Pathol. 1966 Jan;19(1):73–75. doi: 10.1136/jcp.19.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jenkins P. A., Marks J., Schaefer W. B. Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria. Am Rev Respir Dis. 1971 Feb;103(2):179–187. doi: 10.1164/arrd.1971.103.2.179. [DOI] [PubMed] [Google Scholar]
  15. Kent P. W., Fox W., Miller A. B., Nunn A. J., Tall R., Mitchison D. A. The therapy of pulmonary tuberculosis in Kenya: a comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment services. Tubercle. 1970 Mar;51(1):24–38. doi: 10.1016/0041-3879(70)90125-x. [DOI] [PubMed] [Google Scholar]
  16. Lees A. W., Allan G. W., Smith J., Tyrrell W. F., Fallon R. J. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy. Tubercle. 1971 Sep;52(3):182–190. doi: 10.1016/0041-3879(71)90041-9. [DOI] [PubMed] [Google Scholar]
  17. Lees A. W., Asgher B., Hashem M. A., Sinha B. N. Jaundice after rifampicin. Br J Dis Chest. 1970 Apr;64(2):90–95. doi: 10.1016/s0007-0971(70)80034-1. [DOI] [PubMed] [Google Scholar]
  18. Lefford M. J., Mitchison D. A., Tall R. Bacteriological aspects of the second national survey of primary drug resistance in pulmonary tuberculosis, 1963. Tubercle. 1966 Mar;47(1):109–129. doi: 10.1016/s0041-3879(66)80054-5. [DOI] [PubMed] [Google Scholar]
  19. MARKS J. A simple method for the cultivation of tubercle bacilli. Mon Bull Minist Health Public Health Lab Serv. 1959 May;18:81–86. [PubMed] [Google Scholar]
  20. MARKS J. PYRUVIC ACID IN THE CULTIVATION OF TUBERCLE BACILLI. Mon Bull Minist Health Public Health Lab Serv. 1963 Sep;22:150–152. [PubMed] [Google Scholar]
  21. Miller A. B., Fox W., Tall R. An international co-operative investigation into thiacetazone (thioacetazone) side-effects. Tubercle. 1966 Mar;47(1):33–74. doi: 10.1016/s0041-3879(66)80051-x. [DOI] [PubMed] [Google Scholar]
  22. Miller A. B., Nunn A. J., Robinson D. K., Ferguson G. C., Fox W., Tall R. A second international co-operative investigation into thioacetazone side-effects. 1. The influence of a vitamin and antihistamine supplement. Bull World Health Organ. 1970;43(1):107–125. [PMC free article] [PubMed] [Google Scholar]
  23. Miller A. B., Tall R., Fox W., Lefford M. J., Mitchison D. A. Primary drug resistance in pulmonary tuberculosis in Great Britain: second national survey, 1963. Tubercle. 1966 Mar;47(1):92–108. doi: 10.1016/s0041-3879(66)80053-3. [DOI] [PubMed] [Google Scholar]
  24. Mitchison D. A. Examination of sputum by smear and culture in case-finding. Bull Int Union Tuberc. 1968 Dec;41:139–147. [PubMed] [Google Scholar]
  25. Nassau E., Merrick A. J. The fluorescent antibody test in human tuberculosis: a pilot study. Tubercle. 1970 Dec;51(4):430–436. doi: 10.1016/0041-3879(70)90009-7. [DOI] [PubMed] [Google Scholar]
  26. Newman R., Doster B., Murray F. J., Ferebee S. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial. Am Rev Respir Dis. 1971 Apr;103(4):461–476. doi: 10.1164/arrd.1971.103.4.461. [DOI] [PubMed] [Google Scholar]
  27. Nitti V., Catena E., Delli Veneri F., De Michele G., Marra A. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis. Am Rev Respir Dis. 1971 Mar;103(3):329–337. doi: 10.1164/arrd.1971.103.3.329. [DOI] [PubMed] [Google Scholar]
  28. Polansky F. Trial of sanatorium treatment including a comparison of standard and intermittent continuation chemotherapy: Central Bohemian Tuberculosis Services-WHO-British Medical Research Council investigation. Bull Int Union Tuberc. 1970 Jun;43:295–302. [PubMed] [Google Scholar]
  29. Poole G., Stradling P., Worlledge S. Potentially serious side effects of high-dose twice-weekly rifampicin. Br Med J. 1971 Aug 7;3(5770):343–347. doi: 10.1136/bmj.3.5770.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. RUNYON E. H., SELIN M. J., HARRIS H. W. Distinguishing mycobacteria by the niacin test; a modified procedure. Am Rev Tuberc. 1959 May;79(5):663–665. doi: 10.1164/artpd.1959.79.5.663. [DOI] [PubMed] [Google Scholar]
  31. Scharer L., Smith J. P. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med. 1969 Dec;71(6):1113–1120. doi: 10.7326/0003-4819-71-6-1113. [DOI] [PubMed] [Google Scholar]
  32. Springett V. H. Tuberculosis control in Britain 1945-1970-1995. Tubercle. 1971 Jun;52(2):136–147. doi: 10.1016/0041-3879(71)90020-1. [DOI] [PubMed] [Google Scholar]
  33. TSUKAMURA M., TSUKAMURA S. DIFFERENTIATION OF MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM BOVIS BY P-NITROBENZOIC ACID SYSCEPTIBILITY. Tubercle. 1964 Mar;45:64–65. doi: 10.1016/s0041-3879(64)80091-x. [DOI] [PubMed] [Google Scholar]
  34. WAYNE L. G., DOUBEK J. R., RUSSELL R. L. CLASSIFICATION AND IDENTIFICATION OF MYCOBACTERIA. I. TESTS EMPLOYING TWEEN 80 AS SUBSTRATE. Am Rev Respir Dis. 1964 Oct;90:588–597. doi: 10.1164/arrd.1964.90.4.588. [DOI] [PubMed] [Google Scholar]
  35. Young W. D., Jr, Maslansky A., Lefar M. S., Kronish D. P. Development of a paper strip test for detection of niacin produced by mycobacteria. Appl Microbiol. 1970 Dec;20(6):939–945. doi: 10.1128/am.20.6.939-945.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES